Hao-Yuan Chuang
CIK 1992008 · Chief Financial Officer · last filed 2026-10-30
Hao-Yuan Chuang is a Chief Financial Officer who has filed 16 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing, for BLTE, was dated Oct 30, 2026. Across all open-market trades the lifetime net is −$14.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $32.1M across reported positions. 10 Form 144 notices of planned sales are also on file; the latest, for Belite Bio, Inc. on Aug 12, 2026, lists the filer as an officer and director. 63 sales listed on those notices, worth $10.9M in all, have no matching Form 4.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLTE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLTE | Chief Financial Officer | 210,264 | $152.72 | $32.11M | -$14.00M | 6 | 2026-10-30 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| BLTE | Direct | 180,264 | 85.7% | 2026-10-30 |
| By ESHJ Ltd | 30,000 | 14.3% | 2026-10-30 | |
| Total | 210,264 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-30 | BLTE | Other (J) | +5,000 | $0 | EDGAR |
| 2026-09-09 | BLTE | Sell (S)10b5-1 Plan adopted Dec 22, 2025 |
−67,395 | -$12.80M | EDGAR |
| 2026-08-14 | BLTE | Sell (S)10b5-1 Plan adopted Dec 22, 2025 |
−367 | -$66.2K | EDGAR |
| 2026-08-12 | Belite Bio, Inc. | Notice (144) Officer, Director · Planned Aug 12, 2026 · 10b5-1 plan No sale on file |
−93,800 | -$16.66M | EDGAR |
| 2026-04-23 | BLTE | Other (J) | +10,000 | $0 | EDGAR |
| 2026-04-13 | BLTE | Sell (S)10b5-1 Plan adopted Dec 22, 2025 |
−6,200 | -$1.13M | EDGAR |
| 2026-04-09 | Belite Bio, Inc. | Notice (144) Officer, Director · Planned Apr 9, 2026 · 10b5-1 plan No sale on file |
−100,000 | -$17.87M | EDGAR |
| 2026-04-02 | BLTE | Grant (A) | — | $0 | EDGAR |
| 2025-10-14 | Belite Bio, Inc. | Notice (144) Officer, Director · Planned Oct 13, 2025 · 10b5-1 plan No sale on file |
−70,054 | -$5.59M | EDGAR |
| 2025-01-02 | Belite Bio, Inc. | Notice (144) Officer, Director · Planned Jan 2, 2025 · 10b5-1 plan No sale on file |
−160,000 | -$10.10M | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
63 sales · $10.88M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2024-10-23 | Belite Bio, Inc. | 795 | $47.7K | $60.00 | 2025-01-02 |
| 2024-10-22 | Belite Bio, Inc. | 6,705 | $395.2K | $58.94 | 2025-01-02 |
| 2024-10-21 | Belite Bio, Inc. | 1,698 | $96.9K | $57.07 | 2025-01-02 |
| 2024-10-18 | Belite Bio, Inc. | 2,435 | $137.4K | $56.41 | 2025-01-02 |
| 2024-10-17 | Belite Bio, Inc. | 707 | $39.6K | $56.01 | 2025-01-02 |
| 2024-10-16 | Belite Bio, Inc. | 1,707 | $95.7K | $56.06 | 2025-01-02 |
| 2024-10-14 | Belite Bio, Inc. | 953 | $53.6K | $56.19 | 2025-01-02 |
| 2024-10-10 | Belite Bio, Inc. | 3,979 | $220.0K | $55.30 | 2025-01-02 |
| 2024-10-09 | Belite Bio, Inc. | 5,721 | $311.8K | $54.49 | 2025-01-02 |
| 2024-10-08 | Belite Bio, Inc. | 10,300 | $545.9K | $53.00 | 2025-01-02 |
| 2024-10-07 | Belite Bio, Inc. | 2,920 | $149.0K | $51.04 | 2025-01-02 |
| 2024-10-04 | Belite Bio, Inc. | 1,409 | $71.9K | $51.03 | 2025-01-02 |
| 2024-10-03 | Belite Bio, Inc. | 671 | $34.2K | $51.01 | 2025-01-02 |
| 2024-09-20 | Belite Bio, Inc. | 400 | $19.4K | $48.43 | 2024-10-08 |
| 2024-09-19 | Belite Bio, Inc. | 12,833 | $623.3K | $48.57 | 2024-10-08 |
| 2024-09-18 | Belite Bio, Inc. | 6,995 | $339.5K | $48.54 | 2024-10-08 |
| 2024-09-17 | Belite Bio, Inc. | 272 | $13.2K | $48.68 | 2024-10-08 |
| 2024-09-13 | Belite Bio, Inc. | 960 | $46.8K | $48.78 | 2024-10-08 |
| 2024-09-12 | Belite Bio, Inc. | 5,413 | $264.2K | $48.81 | 2024-10-08 |
| 2024-09-11 | Belite Bio, Inc. | 1,055 | $51.4K | $48.77 | 2024-10-08 |
| 2024-09-10 | Belite Bio, Inc. | 635 | $31.1K | $48.93 | 2024-10-08 |
| 2024-09-09 | Belite Bio, Inc. | 6,315 | $309.0K | $48.93 | 2024-10-08 |
| 2024-09-05 | Belite Bio, Inc. | 3,700 | $180.3K | $48.74 | 2024-10-08 |
| 2024-08-29 | Belite Bio, Inc. | 3,508 | $169.0K | $48.17 | 2024-10-08 |
| 2024-08-28 | Belite Bio, Inc. | 18 | $884 | $49.11 | 2024-10-08 |
| 2024-08-27 | Belite Bio, Inc. | 3,900 | $191.1K | $49.00 | 2024-10-08 |
| 2024-08-26 | Belite Bio, Inc. | 305 | $15.0K | $49.10 | 2024-10-08 |
| 2024-08-23 | Belite Bio, Inc. | 1,032 | $50.8K | $49.27 | 2024-10-08 |
| 2024-08-19 | Belite Bio, Inc. | 219 | $10.9K | $49.95 | 2024-10-08 |
| 2024-08-16 | Belite Bio, Inc. | 787 | $39.3K | $49.95 | 2024-10-08 |
| 2024-08-15 | Belite Bio, Inc. | 5,500 | $274.5K | $49.91 | 2024-10-08 |
| 2024-08-14 | Belite Bio, Inc. | 3,297 | $164.5K | $49.89 | 2024-10-08 |
| 2024-06-13 | Belite Bio, Inc. | 4,656 | $232.6K | $49.96 | 2024-08-14 |
| 2024-06-12 | Belite Bio, Inc. | 4,944 | $242.7K | $49.09 | 2024-08-14 |
| 2024-06-10 | Belite Bio, Inc. | 300 | $14.7K | $48.95 | 2024-08-14 |
| 2024-05-30 | Belite Bio, Inc. | 100 | $4.9K | $49.01 | 2024-08-14 |
| 2023-12-06 | Belite Bio, Inc. | 406 | $17.4K | $42.80 | 2023-12-28 |
| 2023-12-01 | Belite Bio, Inc. | 316 | $13.4K | $42.50 | 2023-12-28 |
| 2023-11-30 | Belite Bio, Inc. | 11,519 | $452.0K | $39.24 | 2023-12-28 |
| 2023-11-29 | Belite Bio, Inc. | 5,197 | $197.1K | $37.93 | 2023-12-28 |
| 2023-11-28 | Belite Bio, Inc. | 4,560 | $171.6K | $37.64 | 2023-12-28 |
| 2023-11-27 | Belite Bio, Inc. | 2,863 | $107.7K | $37.62 | 2023-12-28 |
| 2023-11-24 | Belite Bio, Inc. | 3,346 | $126.6K | $37.84 | 2023-12-28 |
| 2023-11-22 | Belite Bio, Inc. | 16,633 | $629.1K | $37.82 | 2023-12-28 |
| 2023-11-21 | Belite Bio, Inc. | 12,303 | $467.4K | $37.99 | 2023-12-28 |
| 2023-11-20 | Belite Bio, Inc. | 8,085 | $305.1K | $37.74 | 2023-12-28 |
| 2023-11-17 | Belite Bio, Inc. | 12,303 | $454.0K | $36.90 | 2023-12-28 |
| 2023-11-16 | Belite Bio, Inc. | 22,469 | $820.2K | $36.51 | 2023-12-28 |
| 2023-09-25 | Belite Bio, Inc. | 672 | $21.3K | $31.70 | 2023-11-16 |
| 2023-09-22 | Belite Bio, Inc. | 900 | $28.0K | $31.11 | 2023-11-16 |
| 2023-09-21 | Belite Bio, Inc. | 2,400 | $72.6K | $30.25 | 2023-11-16 |
| 2023-09-20 | Belite Bio, Inc. | 1,800 | $55.8K | $30.99 | 2023-11-16 |
| 2023-09-19 | Belite Bio, Inc. | 400 | $12.6K | $31.40 | 2023-11-16 |
| 2023-09-18 | Belite Bio, Inc. | 148 | $4.8K | $32.40 | 2023-11-16 |
| 2023-09-15 | Belite Bio, Inc. | 916 | $29.5K | $32.20 | 2023-11-16 |
| 2023-09-14 | Belite Bio, Inc. | 2,500 | $78.7K | $31.48 | 2023-11-16 |
| 2023-09-13 | Belite Bio, Inc. | 1,400 | $43.0K | $30.69 | 2023-11-16 |
| 2023-09-12 | Belite Bio, Inc. | 1,000 | $31.8K | $31.75 | 2023-11-16 |
| 2023-09-08 | Belite Bio, Inc. | 14,445 | $459.8K | $31.83 | 2023-11-16 |
| 2023-09-07 | Belite Bio, Inc. | 6,300 | $198.6K | $31.53 | 2023-11-16 |
| 2023-09-06 | Belite Bio, Inc. | 4,800 | $167.0K | $34.80 | 2023-11-16 |
| 2023-09-05 | Belite Bio, Inc. | 9,500 | $329.1K | $34.64 | 2023-11-16 |
| 2023-08-31 | Belite Bio, Inc. | 2,819 | $97.7K | $34.64 | 2023-11-16 |